Select Publications
Journal articles
2024, 'Exploration of organoids in ovarian cancer: From basic research to clinical translation', Translational Oncology, 50, http://dx.doi.org/10.1016/j.tranon.2024.102130
,2024, 'The emerging role of extracellular vesicles and particles in prostate cancer diagnosis, and risk stratification', Biochimica et Biophysica Acta - Reviews on Cancer, 1879, http://dx.doi.org/10.1016/j.bbcan.2024.189210
,2024, 'Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery', Metabolites, 14, http://dx.doi.org/10.3390/metabo14070367
,2024, 'Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis', Journal of Controlled Release, 371, pp. 126 - 145, http://dx.doi.org/10.1016/j.jconrel.2024.05.029
,2024, 'Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification', Advanced Science, 11, http://dx.doi.org/10.1002/advs.202402509
,2024, 'Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2024-0188
,2023, 'Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein', Radiation Oncology, 18, http://dx.doi.org/10.1186/s13014-023-02369-3
,2023, 'Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics', Journal of Nanobiotechnology, 21, http://dx.doi.org/10.1186/s12951-023-02219-0
,2023, 'Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis', Molecular Cancer, 22, http://dx.doi.org/10.1186/s12943-023-01741-x
,2023, 'Comparison Study of Small Extracellular Vesicle Isolation Methods for Profiling Protein Biomarkers in Breast Cancer Liquid Biopsies', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242015462
,2023, 'Extracellular vesicles as a novel approach for breast cancer therapeutics', Cancer Letters, 555, http://dx.doi.org/10.1016/j.canlet.2022.216036
,2023, 'Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation', Cancer Biology and Therapy, 24, http://dx.doi.org/10.1080/15384047.2023.2287128
,2023, 'Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels', Frontiers in Bioengineering and Biotechnology, 11, http://dx.doi.org/10.3389/fbioe.2023.1264006
,2022, 'Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin', Biomolecules, 12, http://dx.doi.org/10.3390/biom12111623
,2022, 'Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.999643
,2022, 'Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics', THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 14, http://dx.doi.org/10.1177/17588359221118010
,2022, 'Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion', Cell Death and Disease, 13, http://dx.doi.org/10.1038/s41419-022-04510-8
,2022, 'Liquid biopsy of extracellular vesicle biomarkers for prostate cancer personalized treatment decision', Extracellular Vesicles and Circulating Nucleic Acids, 3, pp. 3 - 9, http://dx.doi.org/10.20517/evcna.2021.20
,2021, 'THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer', Advanced Science, 8, http://dx.doi.org/10.1002/advs.202102658
,2021, 'The Emerging Role of Exosomes in Cancer Chemoresistance', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.737962
,2021, 'Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.703537
,2021, 'Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance', Journal of the National Cancer Center, 1, pp. 75 - 87, http://dx.doi.org/10.1016/j.jncc.2021.06.001
,2021, 'Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.679527
,2021, 'Activation of the eIF2 alpha/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', REDOX BIOLOGY, 43, http://dx.doi.org/10.1016/j.redox.2021.101993
,2021, 'Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?', Cancer Letters, 497, pp. 100 - 111, http://dx.doi.org/10.1016/j.canlet.2020.10.016
,2020, 'Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers', Frontiers in Oncology, 10, http://dx.doi.org/10.3389/fonc.2020.598817
,2020, 'Exosomes and breast cancer drug resistance', Cell Death and Disease, 11, http://dx.doi.org/10.1038/s41419-020-03189-z
,2020, 'A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications', Frontiers in Immunology, 11, pp. 1612, http://dx.doi.org/10.3389/fimmu.2020.01612
,2020, 'Exosomes and Nanoengineering: A Match Made for Precision Therapeutics', Advanced Materials, 32, http://dx.doi.org/10.1002/adma.201904040
,2020, 'CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo', Experimental Cell Research, 388, http://dx.doi.org/10.1016/j.yexcr.2020.111850
,2020, 'Aptamer-guided extracellular vesicle theranostics in oncology', Theranostics, 10, pp. 3849 - 3866, http://dx.doi.org/10.7150/thno.39706
,2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, 145, http://dx.doi.org/10.1016/j.critrevonc.2019.102860
,2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486
,2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106
,2019, 'Cancer stem cells in prostate cancer radioresistance', Cancer Letters, 465, pp. 94 - 104, http://dx.doi.org/10.1016/j.canlet.2019.08.020
,2019, 'Exosomes in Cancer Radioresistance', Frontiers in Oncology, 9, http://dx.doi.org/10.3389/fonc.2019.00869
,2019, 'Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5824-9
,2019, 'A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate', Human Gene Therapy Methods, 30, pp. 1 - 16, http://dx.doi.org/10.1089/hgtb.2018.237
,2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, 9, pp. 557, http://dx.doi.org/10.3389/fonc.2019.00557
,2019, 'In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer', Cancer Control, 26, http://dx.doi.org/10.1177/1073274819846590
,2019, 'Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression', Theranostics, 9, pp. 4130 - 4140, http://dx.doi.org/10.7150/thno.34692
,2018, 'Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo', BMC Cancer, 18, pp. 1092, http://dx.doi.org/10.1186/s12885-018-5010-5
,2018, 'Cancer stem cell in breast cancer therapeutic resistance', Cancer Treatment Reviews, 69, pp. 152 - 163, http://dx.doi.org/10.1016/j.ctrv.2018.07.004
,2017, 'Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells', Scientific Reports, 7, pp. 5898, http://dx.doi.org/10.1038/s41598-017-05859-z
,2017, 'Urinary biomarkers in prostate cancer detection and monitoring progression', Critical Reviews in Oncology/Hematology, 118, pp. 15 - 26, http://dx.doi.org/10.1016/j.critrevonc.2017.08.002
,2017, 'Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach', Scientific Reports, 7, pp. 41834, http://dx.doi.org/10.1038/srep41834
,2017, 'Targeting microRNAs in prostate cancer radiotherapy', Theranostics, 7, pp. 3243 - 3259, http://dx.doi.org/10.7150/thno.19934
,2017, 'Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery', Theranostics, 7, pp. 4071 - 4086, http://dx.doi.org/10.7150/thno.20168
,2016, 'Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy', Expert Review of Proteomics, http://dx.doi.org/10.1080/14789450.2016.1233065
,2016, 'Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique', Translational Oncology, 9, pp. 41 - 45, http://dx.doi.org/10.1016/j.tranon.2015.11.011
,